产品中心 药物靶点和Fc受体 小分子药物靶点蛋白

所有图片(1/2)

P53(Y220C) His Tag Protein, Human

TP53,P53,Phosphoprotein p53,Tumor suppressor p53

价格 2,150.00 供应商现货 : 3-5个工作日
货号 UA085060
规格
数量
收藏 分享

产品介绍 评论(0)

产品规格
  • 物种

    Human
  • 分子别名

    TP53, P53, Phosphoprotein p53, Tumor suppressor p53
  • Accession

    P04637
  • 表达序列

    S94-T312, Y220C with His Tag at the N-Terminus

  • 表达宿主

    E.coli
  • 分子量

    25-35kDa (Reducing)
  • 纯度

    >95% by SDS-PAGE & HPLC
  • 标记

    Unconjugated
  • 标签

    His Tag
  • 性状

    Liquid
  • 缓冲体系

    50mM Tris, 150mM NaCl, pH7.5, 1mM DTT, 10%Glycerol

  • 储存条件

    Stable for 12 months upon stored at -80℃ from the date of receipt. And avoid repeated freeze-thaws cycles.

  • 文献引用

    1. Restoration of the Tumor Suppressor Function of Y220C-Mutant p53 by Rezatapopt, a Small-Molecule Reactivator. Cancer Discovery, 15(6), 1159-1179.2. Tornesello, M.L. (2025). TP53 mutations in cancer: Molecular features and therapeutic opportunities. International Journal of Molecular Medicine, 55(1), 5.
    2. Tornesello, M.L. (2025). TP53 mutations in cancer: Molecular features and therapeutic opportunities. International Journal of Molecular Medicine, 55(1), 5.
    3. Lane, D.P. (1992). Cancer. p53, guardian of the genome. Nature, 358(6381), 15-16.

背景介绍
  • P53-Y220C is one of the most representative conformational mutants of the TP53 gene, resulting from a substitution of tyrosine to cysteine at position 220. This mutation is located on the surface of the DNA-binding domain (DBD) and does not directly participate in DNA contact. The Y220C mutation creates a surface crevice or “pocket” within the protein core, severely disrupting the thermodynamic stability of the p53 protein. This causes it to undergo conformational changes and aggregate at physiological temperatures, leading to a loss of DNA-binding ability and transcriptional activation function.

    In contrast to many other types of mutations, the unique crevice created by the Y220C mutation provides an excellent “druggable” target for the development of small-molecule “chaperone” drugs. These small molecules can precisely bind to this crevice, acting like “glue” to stabilize the folded conformation of the p53 protein, thereby restoring its tumor suppressor function. Consequently, P53-Y220C has become one of the most intensively studied and advanced mutation targets in the field of p53-targeted therapeutics.

  • 电泳

    • 2μg (R: reducing condition, N: non-reducing condition).

  • 反相高效液相色谱(RP-HPLC)

    • The purity of P53(Y220C) His Tag Protein, Human is more than 95% determined by RP-HPLC.

评论(0)